MedPath
FDA Approval

Multaq

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 3, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Dronedarone(400 mg in 1 1)

Manufacturing Establishments3

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Sanofi Winthrop Industrie

sanofi-aventis U.S. LLC

571879985

Sanofi Chimie

sanofi-aventis U.S. LLC

262600765

Genzyme Corporation

sanofi-aventis U.S. LLC

050424395

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Multaq

Product Details

NDC Product Code
0024-4142
Application Number
NDA022425
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
October 31, 2023
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
starch, cornInactive
Code: O8232NY3SJClass: IACT
lactose monohydrateInactive
Code: EWQ57Q8I5XClass: IACT
poloxamer 407Inactive
Code: TUF2IVW3M2Class: IACT
polyethylene glycol 6000Inactive
Code: 30IQX730WEClass: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4Class: IACT
magnesium stearateInactive
Code: 70097M6I30Class: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT
carnauba waxInactive
Code: R12CBM0EIZClass: IACT
Code: JQZ1L091Y2Class: ACTIBQuantity: 400 mg in 1 1
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MKClass: IACT
© Copyright 2025. All Rights Reserved by MedPath